Teresa Pokladowski

Teresa is a respected business development strategist, building successful clinical programs for clients in Massachusetts. She is an innovator of fresh approaches to biomarker planning, translational solutions, and clinical study design. Her experience spans the execution of Phase 1-4 clinical trials, specialty lab services, companion and in vitro diagnostic strategies, and biomarker data management.

Read: Clinical Trial Trends Late Phase Oncology

Clinical Trials - Oncology

Clinical Trial Trends Late Phase Oncology

Dec 12, ‘24 | 5 min read
- Natacha Grand
Discover
Read: Clinical Trial Trends: Antibody-Drug Conjugates

Clinical Trials - Oncology

Clinical Trial Trends: Antibody-Drug Conjugates

Dec 10, ‘24 | 5 min read
- Natacha Grand
Discover
Read: Clinical Trial Trends: Early Phase Rare Oncology 

Clinical Trials - Oncology - Rare Diseases

Clinical Trial Trends: Early Phase Rare Oncology 

Dec 03, ‘24 | 5 min read
- Robert Bauer
Discover
Read: Custom FSP Models That Help Biotechs Scale Smarter

Clinical Trials

Custom FSP Models That Help Biotechs Scale Smarter

Dec 01, ‘24 | 7 min read
- Nithiya Ananthakrishnan
Discover
Read: Chevron Deference: A New Era for Biotech

Manufacturing

Chevron Deference: A New Era for Biotech

Nov 20, ‘24 | 1 min read
- Anshul Mangal
Discover
Read: Protocol Study Design: Bridging Clinical Goals with Patient Needs

Clinical Trials

Protocol Study Design: Bridging Clinical Goals with Patient Needs

Nov 18, ‘24 | 4 min read
- Ana Magalhaes
Discover
Read: Optimizing Immunohistochemistry Validation and Regulatory Strategies

Translational Research - Biomarkers - Assays

Optimizing Immunohistochemistry Validation and Regulatory Strategies

Nov 15, ‘24 | 8 min read
- Kennon D.
- Christie .
Discover
Read: Expediting Clinical Trial Study Start-up in Australia

Expediting Clinical Trial Study Start-up in Australia

Nov 14, ‘24 | 6 min read
- Helen Ormandy, PhD
Discover
Read: Rescuing a Complex Hematology Oncology Trial: Case Study in Precision

Clinical Trials

Rescuing a Complex Hematology Oncology Trial: Case Study in Precision

Nov 13, ‘24 | 4 min read
- Anne K.
  
  Andrea C.
  
  Hasni M.
Discover
Read: Lean Authoring: Bringing Efficiency and Speed to Clinical Study Reports

Clinical Trials

Lean Authoring: Bringing Efficiency and Speed to Clinical Study Reports

Nov 05, ‘24 | 6 min read
- Meredith Latino
Discover
Read: What Is an FDA Breakthrough Therapy Designation?

Clinical Trials - Regulatory

What Is an FDA Breakthrough Therapy Designation?

Nov 04, ‘24 | 8 min read
- Harpreet Singh, MD
Discover
Read: Women Leaders Share Raw Truths About Leadership in Life Sciences

Clinical Trials - Translational Research

Women Leaders Share Raw Truths About Leadership in Life Sciences

Oct 23, ‘24 | 5 min read
- Rob M.
- Niveda R.
Discover
Read: Challenges & Opportunities in Cell and Gene Therapy

Manufacturing

Challenges & Opportunities in Cell and Gene Therapy

Oct 15, ‘24 | 1 min read
- Anshul Mangal
Discover
Read: How European Oncology Site Networks Streamline Clinical Trial Site Selection

Clinical Trials - Oncology

How European Oncology Site Networks Streamline Clinical Trial Site Selection

Oct 14, ‘24 | 6 min read
- Deana Demjen
Discover
Read: Clinical Trial Trends: Early Phase Oncology

Clinical Trials - Early Phase Research - Oncology

Clinical Trial Trends: Early Phase Oncology

Oct 12, ‘24 | 4 min read
- Natacha Grand
Discover
Read: The Dose Dilemma: Lessons from Sotorasib and the Future of Oncology Drug Optimization

Clinical Trials - Oncology

The Dose Dilemma: Lessons from Sotorasib and the Future of Oncology Drug Optimization

Oct 11, ‘24 | 6 min read
- Harpreet Singh, MD
Discover
Read: Why Antibody-Drug Conjugates Are Revolutionizing Precision Oncology

Clinical Trials - Oncology

Why Antibody-Drug Conjugates Are Revolutionizing Precision Oncology

Oct 11, ‘24 | 9 min read
- Ivan Barrera
Discover
Read: Therapeutic Genome Editing – Reshaping the Landscape of Advanced Therapies

Regulatory - Gene Therapies

Therapeutic Genome Editing – Reshaping the Landscape of Advanced Therapies

Oct 10, ‘24 | 2 min read
- Precision Experts
Discover
Read: Clinical Trial Trends: Non-Hodgkin’s Lymphoma

Clinical Trials - Oncology

Clinical Trial Trends: Non-Hodgkin’s Lymphoma

Sep 24, ‘24 | 6 min read
- Jen Vance
Discover
Read: US Crackdown on Chinese Clinical Trials: What’s at Stake for Biopharma?

Manufacturing

US Crackdown on Chinese Clinical Trials: What’s at Stake for Biopharma?

Sep 18, ‘24 | 1 min read
- Anshul Mangal
Discover
Read: Safety isn’t a Milestone but a Mindset in Clinical Research

Clinical Trials

Safety isn’t a Milestone but a Mindset in Clinical Research

Sep 16, ‘24 | 6 min read
- Renise Blythe
Discover
Read: Will BIOSECURE Boost US Pharma?

Manufacturing

Will BIOSECURE Boost US Pharma?

Sep 13, ‘24 | 1 min read
- Anshul Mangal
Discover
Read: Advancing Equity in Clinical Trials: Unpacking the FDA’s Diversity Guidance

Clinical Trials

Advancing Equity in Clinical Trials: Unpacking the FDA’s Diversity Guidance

Sep 12, ‘24 | 6 min read
- Rosamund R.
- Harpreet S.
Discover
Read: Case Study: Effective Management of a Rescue Study

Clinical Trials

Case Study: Effective Management of a Rescue Study

Sep 09, ‘24 | 7 min read
- Jason Valentino
Discover
Read: Case Study: A Double Rescue in Advanced Solid Tumor Clinical Trials

Clinical Trials - Oncology

Case Study: A Double Rescue in Advanced Solid Tumor Clinical Trials

Sep 05, ‘24 | 5 min read
- Joy T.
  
  Kurt P.
  
  Ijeoma O.
Discover
Read: How South Korea Became a Leading Destination for Clinical Trials

Clinical Trials

How South Korea Became a Leading Destination for Clinical Trials

Sep 05, ‘24 | 5 min read
- Helen Ormandy, PhD
Discover
Read: Immunohistochemistry in Precision Medicine: From Biomarker to Clinical Trial Assay

Translational Research - Biomarkers - Assays

Immunohistochemistry in Precision Medicine: From Biomarker to Clinical Trial Assay

Sep 02, ‘24 | 11 min read
- Amanda W.
- Dawn B.
Discover
Read: The Bottom Line on Chevron's Overturn

Manufacturing

The Bottom Line on Chevron's Overturn

Aug 23, ‘24 | 1 min read
- Anshul Mangal
Discover
Read: Clinical Trial Trends: Multiple Myeloma

Clinical Trials - Oncology

Clinical Trial Trends: Multiple Myeloma

Aug 21, ‘24 | 6 min read
- Jen Vance
Discover
Read: Clinical Trial Trends: Rare Oncology vs Non-Oncology

Oncology - Rare Diseases

Clinical Trial Trends: Rare Oncology vs Non-Oncology

Aug 19, ‘24 | 5 min read
- Robert Bauer
Discover
Read: AI's Role in Reshaping Drug Development: FDA Workshop Recap

Clinical Trials

AI's Role in Reshaping Drug Development: FDA Workshop Recap

Aug 13, ‘24 | 5 min read
- Rob Maiale
Discover
Read: Clinical Trial Trends: Ovarian Cancer

Oncology

Clinical Trial Trends: Ovarian Cancer

Aug 12, ‘24 | 3 min read
- Andy Kinley
Discover
Read: Lessons Learned from a Rare Pediatric Case Study

Rare Diseases

Lessons Learned from a Rare Pediatric Case Study

Aug 12, ‘24 | 6 min read
- Vincent Shortino
Discover
Read: Inside a CRO: Operational Strategy and Excellence

Clinical Trials

Inside a CRO: Operational Strategy and Excellence

Aug 05, ‘24 | 2 min read
- Andy Kinley
Discover
Read: FDA Approves Breakthrough Cell Therapy for Synovial Sarcoma

Oncology - Cell Therapies

FDA Approves Breakthrough Cell Therapy for Synovial Sarcoma

Aug 05, ‘24 | 4 min read
- Andy Kinley
Discover
Read: FDA ODAC Vote: Key Changes for Perioperative Cancer Trials

Regulatory - Oncology

FDA ODAC Vote: Key Changes for Perioperative Cancer Trials

Aug 01, ‘24 | 5 min read
- Harpreet Singh, MD
Discover
Read: Top Clinical Research Organizations for Oncology in 2024

Clinical Trials - Oncology

Top Clinical Research Organizations for Oncology in 2024

Jul 18, ‘24 | 8 min read
- Rob Maiale
Discover
Read: Perspectives on the Future of the BIOSECURE Act

Manufacturing

Perspectives on the Future of the BIOSECURE Act

Jul 18, ‘24 | 2 min read
- Anshul Mangal
Discover
Read: Bracing for Impact of BIOSECURE Act

Manufacturing

Bracing for Impact of BIOSECURE Act

Jul 17, ‘24 | 1 min read
- Anshul Mangal
Discover
Read: Clinical Trial Trends: Rare Cardiovascular

Rare Diseases

Clinical Trial Trends: Rare Cardiovascular

Jul 17, ‘24 | 4 min read
- Robert Bauer
Discover
Read: Clinical Trial Trends: Rare Autoimmune

Rare Diseases

Clinical Trial Trends: Rare Autoimmune

Jul 16, ‘24 | 5 min read
- Robert Bauer
Discover
Read: Clinical Trial Trends: Rare Oncology

Rare Diseases

Clinical Trial Trends: Rare Oncology

Jul 16, ‘24 | 4 min read
- Robert Bauer
Discover
Read: Clinical Trial Trends: Rare Metabolic

Rare Diseases

Clinical Trial Trends: Rare Metabolic

Jul 16, ‘24 | 4 min read
- Robert Bauer
Discover
Read: Clinical Trial Trends: Radiopharmaceuticals

Clinical Trials - Oncology

Clinical Trial Trends: Radiopharmaceuticals

Jun 28, ‘24 | 5 min read
- Andy Kinley
Discover
Read: Clinical Trial Trends: Rare Pediatric

Rare Diseases

Clinical Trial Trends: Rare Pediatric

Jun 13, ‘24 | 5 min read
- Robert Bauer
Discover

Loading...

You've reach the end